查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511935

药品市场规模、份额和趋势分析报告：按产品类型、按地区、细分市场预测，2024-2030 年

Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Retail Pharmacy, ePharmacy), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

医药市场的成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球药品市场规模预计将达到2.6兆美元，2024年至2030年复合年增长率为7.28%。

这是由于占处方药支出大部分的特殊药物的使用趋势，以及慢性病的流行导致对处方药的需求增加。根据规划与评估助理部长 2022 年 9 月的统计数据，2021 年特种药物占美国所有零售药物支出的 40% 以上，约占非零售药物支出的 70%。

近年来，由于技术进步，市场发生了巨大变化。最大的进步之一是电子健康记录（EHR）的使用。电子病历允许药剂师即时存取和更新患者的医疗资讯。这提高了处方笺填写的效率和准确性，减少了错误，并提高了病人的安全。另一项进步是机器人配药系统，它可以快速且准确地处方笺，从而腾出药剂师的时间来提供其他患者照护服务。远距药事照护是另一项新兴技术，它允许药剂师向服务不足地区的患者远端提供咨询和处方笺配药服务。例如，2020年11月，亚马逊推出Amazon Pharmacy在美国销售处方药。药房透过使用自动化系统和机器人进行包装、贴标、填充和配药，提高了效率并减少了处方笺填充时间。

药品市场报告亮点

  • 以产品来看，2023年处方笺领域将占最大份额。该领域的成长预计将受到医疗专业人员为治疗癌症、糖尿病和心血管疾病等慢性病开出的处方笺数量增加的推动。
  • 按类型划分，零售药房业务在 2023 年占据最大收益占有率。这一增长是由独立药局和连锁店的增加所推动的，这些药局和连锁店提供处方笺配药以外的各种服务，例如免疫服务和健康管理计划。例如，CVS Health 提供糖尿病护理和慢性肾臟病(CKD) 管理等健康管理计划，有助于市场扩张。
  • 由于人口老化、处方药需求增加以及电子药局服务日益普及等因素，北美在 2023 年占据市场主导地位。
  • 2023 年 12 月，Rite Aid Corp. 与费城飞人队合作。此次合作旨在增强费城飞人队在球迷和球场观众中的品牌知名度。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 相关/辅助市场展望
  • 市场趋势及展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 行业机会
    • 产业挑战
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTEL分析
  • COVID-19 影响分析

第四章 产品经营分析

  • 医药市场：产品波动分析
  • 产品市场：细分仪表板
  • 2023年及2030年产品趋势及产品市场占有率分析
  • 副产品
  • 处方笺
  • OTC

第五章 类型业务分析

  • 药品市场：类型变异分析
  • 类型市场：细分仪表板
  • 2023 年和 2030 年类型趋势和市场占有率分析
  • 按类型
  • 医院药房
  • 零售药房
  • 网路药局
  • 其他的

第六章 区域业务分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 北美药局市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲药局市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 亚太地区药品市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲药品市场估计与预测，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲药品市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 公司分类
  • 策略规划
    • 扩张
    • 併购
    • 新服务开始
    • 伙伴关係/协作
    • 其他的
  • 公司市场分析
  • 公司简介/上市公司
    • CVS Health
    • Boots Walgreens
    • Cigna
    • Walmart
    • Kroger
    • Rite Aid Corporation
    • Lloyd Pharmacy
    • Well Pharmacy
    • Humana Pharmacy Solutions
    • Matsumoto Kiyoshi
    • Apollo Pharmacy
    • MedPlusMart.com.
Product Code: GVR-4-68039-701-1

Pharmacy Market Growth & Trends:

The global pharmacy market size is anticipated to reach USD 2.06 trillion by 2030, growing at a CAGR of 7.28% from 2024 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the growing demand for prescription medications due to a trend towards the use of specialty medications, which account for a significant portion of prescription drug spending, and the increasing prevalence of chronic diseases. According to the Assistant Secretary for Planning and Evaluation statistics of September 2022, in 2021, specialty drugs accounted for more than 40% of overall retail drug spending and around 70% of the no-retail drug spending in the U.S.

Technological advancements have transformed the market in recent years. One of the most significant advancements is using Electronic Health Records (EHRs), which allow pharmacists to access and update patient medical information in real-time. This has improved the efficiency and accuracy of prescription filling, reduced errors, and improved patient safety. Another advancement is robotic dispensing systems, which can fill prescriptions quickly & accurately, freeing up time for pharmacists to provide additional patient care services. Telepharmacy is another emerging technology that allows pharmacists to provide remote consultations and prescription filling services to patients in underserved areas. For instance, in November 2020, Amazon launched Amazon Pharmacy to sell prescription drugs in the U.S. Pharmacies are using automation systems and robots for packaging, labeling, filling, and dispensing to improve efficiency and reduce prescription filling time.

Pharmacy Market Report Highlights:

  • Based on product, prescription segment held the largest share in 2023. The growing number of prescriptions by healthcare professionals for the treatment of chronic conditions such as cancer, diabetes, and cardiovascular diseases is expected to drive the growth of the segment.
  • Based on type, the retail pharmacy segment accounted for the largest revenue share in 2023. This growth is attributed to the increasing number of independent pharmacies and chains offering various services beyond prescription dispensing, such as vaccination services and health management programs. For instance, CVS Health provides health management programs such as diabetes care and chronic kidney disease (CKD) management, contributing to market expansion.
  • North America dominated the market in 2023 due to factors such as the aging population, increasing demand for prescription medications, and the rise in the adoption of e-pharmacy services.
  • In December 2023, Rite Aid Corp partnered with the Philadelphia Flyers. This partnership aimed to help strengthen Philadelphia Flyer's brand awareness among fans and visitors to the arena.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources & Third-Party Perspectives
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
    • 1.8.2. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing prevalence of chronic diseases
      • 3.3.1.2. Expanding health insurance coverage
      • 3.3.1.3. Technological advancement
      • 3.3.1.4. Increasing demand for specialty drugs
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product Recalls and Lawsuits
      • 3.3.2.2. Lack of trained staff
    • 3.3.3. Industry Opportunities
    • 3.3.4. Industry Challenges
  • 3.4. Business Environment Analysis
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Pharmacy Market: Product Movement Analysis
  • 4.2. Pharmacy Product Market: Segment Dashboard
  • 4.3. Product Movement & Market Share Analysis, 2023 & 2030
  • 4.4. Global Pharmacy Market Estimates & Forecast, by Product
  • 4.5. Prescription
    • 4.5.1. Prescription market, 2018 - 2030 (USD Billion)
  • 4.6. OTC
    • 4.6.1. OTC market, 2018 - 2030 (USD Billion)

Chapter 5. Type Business Analysis

  • 5.1. Pharmacy Market: Type Movement Analysis
  • 5.2. Type Market: Segment Dashboard
  • 5.3. Type Movement & Market Share Analysis, 2023 & 2030
  • 5.4. Global Pharmacy Market Estimates & Forecast, by Type
  • 5.5. Hospital Pharmacy
    • 5.5.1. Hospital Pharmacy market, 2018 - 2030 (USD Billion)
  • 5.6. Retail Pharmacy
    • 5.6.1. Retail Pharmacy market, 2018 - 2030 (USD Billion)
    • 5.6.2. Chain
      • 5.6.2.1. Chain Pharmacy market, 2018 - 2030 (USD Billion)
    • 5.6.3. Independent pharmacy
      • 5.6.3.1. Independent pharmacy market, 2018 - 2030 (USD Billion)
    • 5.6.4. Others
      • 5.6.4.1. Others market, 2018 - 2030 (USD Billion)
  • 5.7. ePharmacy
    • 5.7.1. ePharmacy market, 2018 - 2030 (USD Billion)
  • 5.8. Others
    • 5.8.1. Others market, 2018 - 2030 (USD Billion)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. North America Pharmacy Market, 2018 - 2030 (USD Billion)
    • 6.5.2. U.S.
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. U.S. pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.5.3. Canada
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.5.4. Mexico
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Mexico pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
  • 6.6. Europe
    • 6.6.1. Europe Pharmacy Market, 2018 - 2030 (USD Billion)
    • 6.6.2. UK
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. UK pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
    • 6.6.3. Germany
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Germany pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.4. France
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. France pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.5. Italy
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Italy pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.6. Spain
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Spain pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.8. Norway
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Norway pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.9. Denmark
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework
      • 6.6.9.3. Competitive scenario
      • 6.6.9.4. Denmark pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific Pharmacy Market, 2018 - 2030 (USD Billion)
    • 6.7.2. Japan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Japan pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.3. China
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. China pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.4. India
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. India pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.5. Australia
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Australia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.7. South Korea
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Regulatory framework
      • 6.7.7.3. Competitive scenario
      • 6.7.7.4. South Korea pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.8. Latin America
    • 6.8.1. Latin America Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
    • 6.8.2. Brazil
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Brazil pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.9. MEA
    • 6.9.1. MEA Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
    • 6.9.2. South Africa
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. South Africa pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. Saudi Arabia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.9.4. UAE
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. UAE pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key country dynamics
      • 6.9.5.2. Regulatory framework
      • 6.9.5.3. Competitive scenario
      • 6.9.5.4. Kuwait pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Expansion
    • 7.2.2. Merger & Acquisition
    • 7.2.3. New Service Launch
    • 7.2.4. Partnership/Collaborations
    • 7.2.5. Others
  • 7.3. Company market position analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. CVS Health
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Service Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boots Walgreens
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Service Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Cigna
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Service Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Walmart
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Service Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Kroger
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Service Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Rite Aid Corporation
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Service Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Lloyd Pharmacy
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Service Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Well Pharmacy
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Service Benchmarking
      • 7.4.8.4. Strategic Initiatives
      • 7.4.8.5. Strategic Initiatives
    • 7.4.9. Humana Pharmacy Solutions
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Service Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Matsumoto Kiyoshi
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Service Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Apollo Pharmacy
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Service Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. MedPlusMart.com.
      • 7.4.12.1. Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Service Benchmarking
      • 7.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 4 Global pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 5 Global pharmacy market, by region, 2018 - 2030 (USD Billion)
  • Table 6 North America pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 8 North America pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 9 U.S.pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 10 U.S pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Canada pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 12 Canada pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Mexico pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 14 Mexico pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 15 Europe pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 17 Europe pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 18 UK pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 19 UK pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 20 Germany pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 21 Germany pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 22 France pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 23 France pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 24 Italy pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 25 Italy pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 26 Spain pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 27 Spain pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 28 Sweden pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 29 Sweden pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Norway pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 31 Norway pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 32 Denmark pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 33 Denmark pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 37 Japan pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 38 Japan pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 39 China pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 40 China pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 41 India pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 42 India pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 43 Australia pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 44 Australia pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 45 Thailand pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Thailand pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 47 South Korea pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 48 South Korea pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Latin America pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 50 Latin America pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 51 Latin America pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 52 Brazil pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 53 Brazil pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 54 Argentina pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 55 Argentina pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 56 Middle East & Africa pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 58 Middle East & Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 59 South Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 60 South Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 61 Saudi Arabia pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 63 UAE pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 64 UAE pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 65 Kuwait pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait pharmacy market, by type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Pharmacy market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Data triangulation techniques
  • Fig. 5 Primary research pattern
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modelling for market share assessment
  • Fig. 9 Market formulation & validation
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation
  • Fig. 12 Competitive landscape
  • Fig. 13 Global pharmacy market lineage outlook
  • Fig. 14 Pharmacy market dynamics
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Pharmacy market: Porter's five forces analysis
  • Fig. 18 Pharmacy market: PESTLE analysis
  • Fig. 19 Pharmacy market product outlook: Segment dashboard
  • Fig. 20 Pharmacy market: Product movement & market share analysis, 2023 & 2030
  • Fig. 21 Prescription market, 2018 - 2030 (USD Million)
  • Fig. 22 OTC market, 2018 - 2030 (USD Million)
  • Fig. 23 Pharmacy market type outlook: Segment dashboard)
  • Fig. 24 Pharmacy market: type movement & market share analysis, 2023 & 2030
  • Fig. 25 Hospital pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 26 Retail pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 27 Chain pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 28 Independent pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 29 Other retail pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 30 ePharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 31 Other pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 34 U.S key country dynamics
  • Fig. 35 U.S pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 38 Mexico key country dynamic
  • Fig. 39 Mexico pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 40 Europe pharmacy market, 2017 - 2030 (USD Billion)
  • Fig. 41 UK key country dynamic
  • Fig. 42 UK pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 43 Germany key country dynamic
  • Fig. 44 Germany pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 45 France key country dynamic
  • Fig. 46 France pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 47 Italy key country dynamic
  • Fig. 48 Italy pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 49 Spain key country dynamic
  • Fig. 50 Spain pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 51 Denmark key country dynamic
  • Fig. 52 Denmark pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 53 Sweden key country dynamic
  • Fig. 54 Sweden pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 55 Norway key country dynamic
  • Fig. 56 Norway pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 57 Asia Pacific pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 58 China key country dynamic
  • Fig. 59 China pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 60 Japan key country dynamic
  • Fig. 61 Japan pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 62 India key country dynamic
  • Fig. 63 India pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 64 South Korea key country dynamic
  • Fig. 65 South Korea pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 66 Australia key country dynamic
  • Fig. 67 Australia pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 68 Thailand key country dynamic
  • Fig. 69 Thailand pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 70 Latin America pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 71 Brazil key country dynamic
  • Fig. 72 Brazil pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 73 Argentina key country dynamic
  • Fig. 74 Argentina pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 75 MEA pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 76 South Africa key country dynamic
  • Fig. 77 South Africa pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 78 Saudi Arabia key country dynamic
  • Fig. 79 Saudi Arabia pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 80 UAE key country dynamic
  • Fig. 81 UAE pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 82 Kuwait key country dynamic
  • Fig. 83 Kuwait pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework